Deuterium Capital Management »

Ikena Oncology shares owned by Deuterium Capital Management

Quarter-by-quarter ownership of Ikena Oncology (IKNA) shares owned by Deuterium Capital Management from 13F filings

Historical chart of Deuterium Capital Management investment in Ikena Oncology

Tip: Access up to 7 years of quarterly data

All positions including Ikena Oncology held by Deuterium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ikena Oncology by Deuterium Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $133k 81k 1.65

More positions owned by Deuterium Capital Management

Oracle Corporation (ORCL)
Intuitive Surgical Com New (ISRG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Enovix Corp (ENVX)
Microsoft Corporation (MSFT)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)
Capri Holdings SHS (CPRI)
Imperial Pete Com New (IMPP)
Global X Fds Global X Uranium (URA)
Robinhood Mkts Com Cl A (HOOD)
Core Scientific (CORZ)
Sony Group Corp Sponsored Adr (SONY)
Sprott Fds Tr Uranium Miners E (URNM)

View all positions for Deuterium Capital Management

Top funds holding Ikena Oncology

Atlas Venture Life Science Advisors
BVF
Blue Owl Capital Holdings
OrbiMed Advisors
Omega Fund Management
Vanguard Group
BML Capital Management
NEA Management Company
Acuitas Investments
Renaissance Technologies
Jacobs Levy Equity Management
Sofinnova Ventures
BlackRock
BlackRock
Acadian Asset Management

View all funds holding Ikena Oncology